PVLA Stock Price
Palvella Therapeutics, Inc.
PVLA stock price is $125.26 (+2.18% on the day), giving Palvella Therapeutics, Inc. a market cap of $1.77B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
PVLA Stock Overview
- Price
- $125.25
- Previous close
- $122.58
- Open
- $123.58
- Market cap
- $1.77B
- P/E ratio
- -42.3
- 52-week range
- $66.58 - $161.38
- 1-year price target
- $229.19
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 38
About Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PVLA | $125.26 | +2.2% | 122.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Palvella Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW